コンテンツへスキップ
Merck
すべての画像(1)

主要文書

すべての文書を表示

安全性情報

H-038

Supelco

ヘロイン 溶液

1.0 mg/mL in acetonitrile, ampule of 1 mL, certified reference material, Cerilliant®

ログイン組織・契約価格を表示する
すべての画像(1)

About This Item

実験式（ヒル表記法）:
C21H23NO5
CAS番号:
561-27-3
分子量:
369.41
MDL番号:
MFCD00468072
UNSPSCコード:
41116107
PubChem Substance ID:
329815115
NACRES:
NA.24

グレード

certified reference material

品質水準

300

フォーム

liquid

特徴

Snap-N-Spike®/Snap-N-Shoot®

包装

ampule of 1 mL

メーカー／製品名

Cerilliant®

drug control

Narcotic Licence Schedule D (Switzerland); estupefaciente (Spain); Decreto Lei 15/93: Tabela IA (Portugal)

濃度

1.0 mg/mL in acetonitrile

テクニック

gas chromatography (GC): suitable
liquid chromatography (LC): suitable

アプリケーション

forensics and toxicology

フォーマット

single component solution

保管温度

−20°C

SMILES記法

CN1CC[C@]23[C@H]4Oc5c(OC(C)=O)ccc(C[C@@H]1[C@@H]2C=C[C@@H]4OC(C)=O)c35

InChI

1S/C21H23NO5/c1-11(23)25-16-6-4-13-10-15-14-5-7-17(26-12(2)24)20-21(14,8-9-22(15)3)18(13)19(16)27-20/h4-7,14-15,17,20H,8-10H2,1-3H3/t14-,15+,17-,20-,21-/m0/s1

InChI Key

GVGLGOZIDCSQPN-PVHGPHFFSA-N

関連するカテゴリー

詳細

Heroin, or diacetylmorphine, is an opiate analgesic most commonly used as an illcit recreational drug. Street heroin is considered to be one of the most harmful recreational drugs due to the use of adulterants and the risk of contracting disease from intravenous use. This drug reference standard is suitable for use in GC/MS or LC/MS heroin testing methods for applications in clinical toxicology, pain prescription monitoring, forensic analysis, and urine drug testing.

法的情報

CERILLIANT is a registered trademark of Merck KGaA, Darmstadt, Germany
Snap-N-Shoot is a registered trademark of Cerilliant Corporation
Snap-N-Spike is a registered trademark of Merck KGaA, Darmstadt, Germany

関連製品

製品番号
詳細
価格

A-009

6-Acetylmorphine, 1.0 mg/mL solution, 1 mg/mL in acetonitrile, ampule of 1 mL, certified reference material, Cerilliant®

A-006

6-Acetylmorphine-d3 solution, 100 μg/mL in acetonitrile, ampule of 1 mL, certified reference material, Cerilliant®

A-010

6-Acetylmorphine-d3 solution, 1.0 mg/mL in acetonitrile, ampule of 1 mL, certified reference material, Cerilliant®

A-003

6-Acetylmorphine, 100 μg/mL solution, 100 μg/mL in acetonitrile, ampule of 1 mL, certified reference material, Cerilliant®

A-026

6-Acetylmorphine-d6 solution, 100 μg/mL in acetonitrile, ampule of 1 mL, certified reference material, Cerilliant®

A-027

6-Acetylmorphine-d6 solution, 1.0 mg/mL in acetonitrile, ampule of 1 mL, certified reference material, Cerilliant®

M-025

Methamphetamine/Cocaine/Heroin solution, 250 μg/mL each component in acetonitrile, ampule of 1.0 mL, certified reference material, Cerilliant®

H-036

Heroin-D9 solution, 100 μg/mL in acetonitrile, ampule of 1 mL, certified reference material, Cerilliant®

H-037

Heroin-D9 solution, 1.0 mg/mL in acetonitrile, ampule of 1 mL, certified reference material, Cerilliant®

ピクトグラム

FlameExclamation mark
GHS02,GHS07

シグナルワード

Danger

危険有害性情報

H225,H302 + H312 + H332,H319

危険有害性の分類

Acute Tox. 4 Dermal - Acute Tox. 4 Inhalation - Acute Tox. 4 Oral - Eye Irrit. 2 - Flam. Liq. 2

保管分類コード

3 - Flammable liquids

WGK

WGK 2

引火点(°F)

35.6 °F - closed cup

引火点(℃)

2 °C - closed cup

適用法令

試験研究用途を考慮した関連法令を主に挙げております。化学物質以外については、一部の情報のみ提供しています。 製品を安全かつ合法的に使用することは、使用者の義務です。最新情報により修正される場合があります。WEBの反映には時間を要することがあるため、適宜SDSをご参照ください。

毒物及び劇物取締法

劇物

消防法

第4類:引火性液体
第一石油類
危険等級II
非水溶性液体

労働安全衛生法名称等を表示すべき危険物及び有害物

名称等を表示すべき危険物及び有害物

労働安全衛生法名称等を通知すべき危険物及び有害物

名称等を通知すべき危険物及び有害物

Jan Code

H-038-1ML:
H-038-CC:

最新バージョンのいずれかを選択してください：

試験成績書（COA）

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our 資料 section.

サポートが必要な場合は、お問い合わせください カスタマーサポート

以前この製品を購入いただいたことがある場合

文書ライブラリで、最近購入した製品の文書を検索できます。

文書ライブラリにアクセスする

I Demaret et al.
Revue medicale de Liege, 68(5-6), 287-293 (2013-07-31)
Heroin (or diacetylmorphine), a depressant nervous central system, is a semi-synthetic opiate. Its main adverse effect, respiratory depression, can lead to death, especially after an intravenous injection. By loss of tolerance, an overdose can be lethal following heroin use after
Alexander B Palchik et al.
Early human development, 89(4), 229-235 (2013-03-16)
Both intra-uterine exposure to maternal drugs and HIV are known to adversely affect the developing central nervous system. (1) To describe the quality of GMs in infants who were intra-uterinely exposed to maternal opiate abuse and HIV; and (2) to
Ellen Kopel et al.
Clinical obstetrics and gynecology, 56(1), 154-165 (2013-01-23)
Recognition that use and abuse of substances by pregnant patients perpetuates, despite ongoing efforts to educate the public, necessitates clinicians to integrate understanding of potential effects on antepartum and intrapartum fetal testing into their interpretation and implementation of clinical findings.
Vanessa J Meyer et al.
Journal of acquired immune deficiency syndromes (1999), 63(1), 67-76 (2013-02-09)
HIV infection and illicit drug use are each associated with diminished cognitive performance. This study examined the separate and interactive effects of HIV and recent illicit drug use on verbal memory, processing speed, and executive function in the multicenter Women's
Stephanie Tobin et al.
The European journal of neuroscience, 37(6), 972-981 (2013-01-17)
The neurotransmitter dopamine (DA) plays a critical role in both priming-and cue-induced reinstatement of extinguished drug-seeking behavior, but its role in stress-induced reinstatement is less clear. Our laboratory has recently demonstrated that systemic administration of the DA D1-like receptor antagonist
関連する文献をすべて表示

プロトコル

HPLC Analysis of Heroin, Cocaine, Amphetamine and MDMA on Ascentis® Express HILIC

Separation of Heroin, analytical standard, ≥98% (HPLC); Cocaine hydrochloride, analytical standard; D-Amphetamine hemisulfate salt solution, 1.0 mg/mL in methanol, analytical standard, for drug analysis; (±)-3,4-Methylenedioxymethamphetamine hydrochloride solution, analytical standard, for drug analysis, 1.0 mg/mL in methanol

ライフサイエンス、有機合成、材料科学、クロマトグラフィー、分析など、あらゆる分野の研究に経験のあるメンバーがおります。.

製品に関するお問い合わせはこちら（テクニカルサービス）